Cancer Research AACR Membership EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, L.
Right arrow Articles by Du, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, L.
Right arrow Articles by Du, J.
[Cancer Research 65, 457-464, January 15, 2005]
© 2005 American Association for Cancer Research

Cell and Tumor Biology

Antiapoptotic Effect of Serum and Glucocorticoid-Inducible Protein Kinase Is Mediated by Novel Mechanism Activating I{kappa}B Kinase

Liping Zhang1, Ruwen Cui1, Xiaodong Cheng2 and Jie Du1,3

Departments of 1 Internal Medicine, 2 Pharmacology and Toxicology, and 3 Human Biological Chemistry & Genetics, University of Texas Medical Branch, Galveston, Texas

Requests for reprints: Jie Du, Department of Internal Medicine, 9.138 Medical Research Building, University of Texas Medical Branch, Galveston, TX 77555-1064. Phone: 409-772-3362; Fax: 409-747-0692; E-mail: jidu{at}utmb.edu.

Serum and glucocorticoid inducible protein kinase (SGK) plays a crucial role in promoting cell survival, but the mechanisms for this response are not clear. We show that SGK is involved in the regulation of apoptosis in breast cancer cells by modulating the transcriptional activity of nuclear transcription factor {kappa}B (NF-{kappa}B). High levels of SGK expression were observed in human breast cancer samples. When SGK was reduced the apoptotic rate increased, and increased SGK activity prevents serum withdrawal–induced apoptosis. SGK-induced cell survival was abolished by a dominant-negative form of I{kappa}B kinase ß (IKKß, K44A) or a null mutation of IKKß in mouse embryonic fibroblast cells indicating involvement of the NF-{kappa}B pathway. Serum-induced SGK or increased expression of SGK activated NF-{kappa}B transcriptional activity, whereas small interference RNA to SGK blocked NF-{kappa}B activity. Coexpression of SGK and IKKß significantly increased the activation of NF-{kappa}B (versus expression of IKKß alone). Expression of dominant-negative IKKß K44A, I{kappa}B{alpha} AA, and kinase-dead SGK (127KM) blocked the ability of SGK to stimulate NF-{kappa}B activity, suggesting that IKKß is a target of SGK. We also show that SGK enhances the ability of IKKß to phosphorylate endogenous I{kappa}B{alpha} in cells or recombinant glutathione S-transferase-I{kappa}B{alpha} in vitro and increases I{kappa}B{alpha} degradation; SGK physically associates with and activates IKKß in MDA231 cells via phosphorylation of Ser181 in IKKß. Taken together, we conclude that SGK acts as an oncogene in breast cancer cells through activation of the IKK-NF-{kappa}B pathway, thereby preventing apoptosis. Blocking SGK expression/activity represents a potential therapeutic approach for breast cancer treatment.

Key Words: Breast cancer • Signal transduction • Survival factors • Transcriptional control of apoptosis




This article has been cited by other articles:


Home page
 Am. J. Physiol. Renal Physiol.Home page
U. Hasler, V. Leroy, P.-Y. Martin, and E. Feraille
Aquaporin-2 abundance in the renal collecting duct: new insights from cultured cell models
Am J Physiol Renal Physiol, July 1, 2009; 297(1): F10 - F18.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
L. Zhang, J. Du, Z. Hu, G. Han, P. Delafontaine, G. Garcia, and W. E. Mitch
IL-6 and Serum Amyloid A Synergy Mediates Angiotensin II-Induced Muscle Wasting
J. Am. Soc. Nephrol., March 1, 2009; 20(3): 604 - 612.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. J. C. Tai, C.-C. Su, Y.-L. Ma, and E. H. Y. Lee
SGK1 Phosphorylation of I{kappa}B Kinase {alpha} and p300 Up-regulates NF-{kappa}B Activity and Increases N-Methyl-D-aspartate Receptor NR2A and NR2B Expression
J. Biol. Chem., February 13, 2009; 284(7): 4073 - 4089.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
V. Leroy, S. De Seigneux, V. Agassiz, U. Hasler, M.-E. Rafestin-Oblin, M. Vinciguerra, P.-Y. Martin, and E. Feraille
Aldosterone Activates NF-{kappa}B in the Collecting Duct
J. Am. Soc. Nephrol., January 1, 2009; 20(1): 131 - 144.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
U. Hasler, V. Leroy, U. S. Jeon, R. Bouley, M. Dimitrov, J. A. Kim, D. Brown, H. M. Kwon, P.-Y. Martin, and E. Feraille
NF-{kappa}B Modulates Aquaporin-2 Transcription in Renal Collecting Duct Principal Cells
J. Biol. Chem., October 17, 2008; 283(42): 28095 - 28105.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
V. Brune, E. Tiacci, I. Pfeil, C. Doring, S. Eckerle, C. J.M. van Noesel, W. Klapper, B. Falini, A. von Heydebreck, D. Metzler, et al.
Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis
J. Exp. Med., September 29, 2008; 205(10): 2251 - 2268.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. B. Sherk, D. E. Frigo, C. G. Schnackenberg, J. D. Bray, N. J. Laping, W. Trizna, M. Hammond, J. R. Patterson, S. K. Thompson, D. Kazmin, et al.
Development of a Small-Molecule Serum- and Glucocorticoid-Regulated Kinase-1 Antagonist and Its Evaluation as a Prostate Cancer Therapeutic
Cancer Res., September 15, 2008; 68(18): 7475 - 7483.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. de Seigneux, V. Leroy, H. Ghzili, M. Rousselot, S. Nielsen, B. C. Rossier, P.-Y. Martin, and E. Feraille
NF-{kappa}B Inhibits Sodium Transport via Down-regulation of SGK1 in Renal Collecting Duct Principal Cells
J. Biol. Chem., September 12, 2008; 283(37): 25671 - 25681.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Belova, D. R. Brickley, B. Ky, S. K. Sharma, and S. D. Conzen
Hsp90 Regulates the Phosphorylation and Activity of Serum- and Glucocorticoid-regulated Kinase-1
J. Biol. Chem., July 4, 2008; 283(27): 18821 - 18831.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
Y. Terada, H. Kuwana, T. Kobayashi, T. Okado, N. Suzuki, T. Yoshimoto, Y. Hirata, and S. Sasaki
Aldosterone-Stimulated SGK1 Activity Mediates Profibrotic Signaling in the Mesangium
J. Am. Soc. Nephrol., February 1, 2008; 19(2): 298 - 309.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
F. Lang, C. Bohmer, M. Palmada, G. Seebohm, N. Strutz-Seebohm, and V. Vallon
(Patho)physiological Significance of the Serum- and Glucocorticoid-Inducible Kinase Isoforms.
Physiol Rev, October 1, 2006; 86(4): 1151 - 1178.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
W. Wu, M. Zou, D. R. Brickley, T. Pew, and S. D. Conzen
Glucocorticoid Receptor Activation Signals through Forkhead Transcription Factor 3a in Breast Cancer Cells
Mol. Endocrinol., October 1, 2006; 20(10): 2304 - 2314.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Yu, J. Yeh, and C. Van Waes
Protein Kinase Casein Kinase 2 Mediates Inhibitor-{kappa}B Kinase and Aberrant Nuclear Factor-{kappa}B Activation by Serum Factor(s) in Head and Neck Squamous Carcinoma Cells.
Cancer Res., July 1, 2006; 66(13): 6722 - 6731.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
R. S. BelAiba, T. Djordjevic, S. Bonello, F. Artunc, F. Lang, J. Hess, and A. Gorlach
The Serum- and Glucocorticoid-Inducible Kinase Sgk-1 Is Involved in Pulmonary Vascular Remodeling: Role in Redox-Sensitive Regulation of Tissue Factor by Thrombin
Circ. Res., March 31, 2006; 98(6): 828 - 836.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
Y. Ma, L. Zhang, T. Peng, J. Cheng, S. Taneja, J. Zhang, P. Delafontaine, and J. Du
Angiotensin II Stimulates Transcription of Insulin-Like Growth Factor I Receptor in Vascular Smooth Muscle Cells: Role of Nuclear Factor-{kappa}B
Endocrinology, March 1, 2006; 147(3): 1256 - 1263.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
L. Zhang, J. Cheng, Y. Ma, W. Thomas, J. Zhang, and J. Du
Dual Pathways for Nuclear Factor {kappa}B Activation by Angiotensin II in Vascular Smooth Muscle: Phosphorylation of p65 by I{kappa}B Kinase and Ribosomal Kinase
Circ. Res., November 11, 2005; 97(10): 975 - 982.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
M. N. Helms, L. Yu, B. Malik, D. J. Kleinhenz, C. M. Hart, and D. C. Eaton
Role of SGK1 in nitric oxide inhibition of ENaC in Na+-transporting epithelia
Am J Physiol Cell Physiol, September 1, 2005; 289(3): C717 - C726.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.